Cameroon Starts World’s First Malaria Vaccine Program For Children

Health officials prepare to vaccinate residents of the Malawi village of Migowi, on Dec. 10, 2019, where young children become test subjects for the world's first vaccine against malaria.
Health officers put together to vaccinate residents of the Malawi village of Migowi, on Dec. 10, 2019, the place younger kids turn into take a look at topics for the world’s first vaccine towards malaria.
AP Photo/Jerome Delay

Cameroon would be the first nation to routinely give kids a brand new malaria vaccine because the photographs are rolled out in Africa.

The marketing campaign as a consequence of begin Monday was described by officers as a milestone within the decades-long effort to curb the mosquito-spread illness on the continent, which accounts for 95% of the world’s malaria deaths.

“The vaccination will save lives. It will provide major relief to families and the country’s health system,” mentioned Aurelia Nguyen, chief program officer on the Gavi vaccines alliance, which helps Cameroon safe the photographs.

The Central Africa nation hopes to vaccinate about 250,000 kids this 12 months and subsequent 12 months. Gavi mentioned it’s working with 20 different African international locations to assist them get the vaccine and that these international locations will hopefully immunize greater than 6 million kids by means of 2025.

In Africa, there are about 250 million instances of the parasitic illness every year, together with 600,000 deaths, principally in younger kids.

Cameroon will use the primary of two lately authorized malaria vaccines, generally known as Mosquirix. The World Health Organization endorsed the vaccine two years in the past, acknowledging that that although it’s imperfect, its use would nonetheless dramatically cut back extreme infections and hospitalizations.

The GlaxoSmithKline-produced shot is simply about 30% efficient, requires 4 doses and safety begins to fade after a number of months. The vaccine was examined in Africa and utilized in pilot applications in three international locations.

GSK has mentioned it could solely produce about 15 million doses of Mosquirix a 12 months and a few specialists imagine a second malaria vaccine developed by Oxford University and authorized by WHO in October may be a extra sensible answer. That vaccine is cheaper, requires three doses and India’s Serum Institute mentioned they might make as much as 200 million doses a 12 months.

Gavi’s Nguyen mentioned they hoped there may be sufficient of the Oxford vaccines out there to start immunizing individuals later this 12 months.

Neither of the malaria vaccines cease transmission, so different instruments like mattress nets and insecticidal spraying will nonetheless be crucial. The malaria parasite principally spreads to individuals through contaminated mosquitoes and might trigger signs together with fever, complications and chills.

___

The Associated Press Health and Science Department receives help from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely chargeable for all content material.

Support HuffPost